0001708138-21-000020.txt : 20210518 0001708138-21-000020.hdr.sgml : 20210518 20210518160414 ACCESSION NUMBER: 0001708138-21-000020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210514 FILED AS OF DATE: 20210518 DATE AS OF CHANGE: 20210518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STAHL NEIL CENTRAL INDEX KEY: 0001226689 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 21935943 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-05-14 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001226689 STAHL NEIL 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 EVP Research and Development Common Stock 2021-02-25 5 G 0 435 0.0 D 24280 D Common Stock 2021-05-14 4 M 0 40000 179.13 A 64280 D Common Stock 2021-05-14 4 F 0 27775 516.69 D 36505 D Common Stock 2021-05-14 4 M 0 12500 52.03 A 49005 D Common Stock 2021-05-14 4 F 0 7204 516.69 D 41801 D Common Stock 2021-05-17 4 S 0 3379 518.63 D 38422 D Common Stock 2021-05-17 4 S 0 10336 519.47 D 28086 D Common Stock 2021-05-17 4 S 0 3806 520.17 D 24280 D Common Stock 5787 I By 401(k) Plan Common Stock 9134 I by 2019 GRAT Non-Qualified Stock Option (right to buy) 52.03 2021-05-14 4 M 0 12500 0.0 D 2021-12-16 Common Stock 12500 0 D Non-Qualified Stock Option (right to buy) 179.13 2021-05-14 4 M 0 40000 0.0 D 2022-12-14 Common Stock 40000 72500 D Represents volume-weighted average price of sales of 3,379 shares of Company stock on May 17, 2021 at prices ranging from $518.02 to $518.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2021 at each separate price. Represents volume-weighted average price of sales of 10,336 shares of Company stock on May 17, 2021 at prices ranging from $519.00 to $519.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2021 at each separate price. Represents volume-weighted average price of sales of 3,806 shares of Company stock on May 17, 2021 at prices ranging from $520.02 to $520.61. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on May 17, 2021 at each separate price. The option became exercisable on December 31, 2014, based upon the satisfaction by the Company of certain performance criteria during the period ended December 31, 2014. The stock option award vested in four equal annual installments, commencing one year after the date of grant. /s/**Neil Stahl 2021-05-18